Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.

Do, Eun-Ju

Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3. [electronic resource] - Journal of gastroenterology and hepatology Aug 2016 - 1453-61 p. digital

Publication Type: Journal Article

1440-1746

10.1111/jgh.13280 doi


Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Anticarcinogenic Agents--pharmacology
Azoxymethane
Cell Transformation, Neoplastic--drug effects
Colitis--chemically induced
Colon--drug effects
Colorectal Neoplasms--etiology
Dextran Sulfate
Disease Models, Animal
Gastrointestinal Agents--pharmacology
Inflammation Mediators--metabolism
Interleukin-6--metabolism
Macrophages--drug effects
Male
Mesalamine--pharmacology
Mice, Inbred C57BL
Phenylhydrazines--pharmacology
Phosphorylation
Probiotics--pharmacology
Proto-Oncogene Proteins c-bcl-2--metabolism
STAT3 Transcription Factor--metabolism
Signal Transduction--drug effects
Time Factors
bcl-2-Associated X Protein--metabolism